deltatrials

Colorectal carcinoma Trials in Barcelona, Spain

Conditions / Colorectal carcinoma / Barcelona, Spain

Colorectal carcinoma has been the subject of sustained clinical investigation across multiple research sites.

10 total trials for this combination

Trials

NCT ID Title Status Phase
NCT00305188 Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. COMPLETED PHASE3
NCT00862784 A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer COMPLETED PHASE2
NCT05358249 Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation ACTIVE_NOT_RECRUITING
NCT02611024 Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors COMPLETED PHASE1/PHASE2
NCT03152565 Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients COMPLETED PHASE1/PHASE2
NCT03142516 FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status COMPLETED PHASE2
NCT07124884 5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab NOT_YET_RECRUITING PHASE2
NCT03377361 An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread COMPLETED PHASE1/PHASE2
NCT06889883 Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer RECRUITING
NCT02273167 Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults. COMPLETED PHASE3

Related Pages